{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:43:22Z","timestamp":1786236202025,"version":"build-2736575974"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/4-5\/3\/5\/DHR\/Neuro\/2020-NCD-I"],"award-info":[{"award-number":["5\/4-5\/3\/5\/DHR\/Neuro\/2020-NCD-I"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016045","name":"University of Central Punjab","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025322","name":"Maharaja Ranjit Singh Punjab Technical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejphar.2026.179084","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:26:35Z","timestamp":1782257195000},"page":"179084","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["From synapses to tangles: PDE inhibitors as therapeutic modulators in Alzheimer's disease"],"prefix":"10.1016","volume":"1030","author":[{"given":"Kajal","family":"Bagri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush","family":"Damde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179084_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10787-022-01059-y","article-title":"Vinpocetine restores cognitive and motor functions in traumatic brain injury challenged rats","volume":"30","author":"Bagri","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejphar.2026.179084_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13195-018-0352-4","article-title":"Amyloid \u03b2-induced impairments on mitochondrial dynamics, hippocampal neurogenesis, and memory are restored by phosphodiesterase 7 inhibition","volume":"10","author":"Bartolome","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.ejphar.2026.179084_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1212\/WNL.0000000000005807","article-title":"Glutamatergic synaptic plasticity and dysfunction in Alzheimer disease: emerging mechanisms","volume":"91","author":"Benarroch","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2026.179084_bib5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1353\/pbm.2012.0017","article-title":"Earl Sutherland (1915-1975) and the discovery of cyclic AMP","volume":"55","author":"Blumenthal","year":"2012","journal-title":"Perspect. Biol. Med."},{"key":"10.1016\/j.ejphar.2026.179084_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177558","article-title":"Neuroprotective effect of perillyl alcohol in sporadic Alzheimer's disease in rats","volume":"996","author":"Chauhan","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179084_bib7","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1007\/s12035-021-02487-7","article-title":"Defective autophagy and mitophagy in Alzheimer's disease: mechanisms and translational implications","volume":"58","author":"Chen","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2026.179084_bib8","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1021\/acschemneuro.0c00106","article-title":"PDE-7 inhibitor BRL-50481 reduces neurodegeneration and long-term memory deficits in mice following sevoflurane exposure","volume":"11","author":"Chen","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179084_bib10","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.pneurobio.2010.01.002","article-title":"Epigenetic regulation in the pathophysiology of Alzheimer's disease","volume":"90","author":"Chouliaras","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2026.179084_bib11","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/ijnp\/pyad042","article-title":"Rolipram ameliorates memory deficits and depression-like behavior in APP\/PS1\/tau triple transgenic mice: involvement of neuroinflammation and apoptosis via cAMP signaling","volume":"26","author":"Cong","year":"2023","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2026.179084_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-015-0142-9","article-title":"Concomitant histone deacetylase and phosphodiesterase 5 inhibition synergistically prevents the disruption in synaptic plasticity and it reverses cognitive impairment in a mouse model of Alzheimer's disease","volume":"7","author":"Cuadrado-Tejedor","year":"2015","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.ejphar.2026.179084_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2009.08.027","article-title":"Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine - a PDE1 inhibitor","volume":"620","author":"Deshmukh","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179084_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117009","article-title":"Beyond PDE4 inhibition: a comprehensive review on downstream cAMP signaling in the central nervous system","volume":"177","author":"Donders","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.179084_bib15","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.3390\/ijms22073330","article-title":"Alzheimer's disease pathogenesis: role of autophagy and mitophagy focusing in microglia","volume":"22","author":"Eshraghi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179084_bib16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s11011-018-0374-4","article-title":"Roflumilast ameliorates cognitive impairment in APP\/PS1 mice via cAMP\/CREB\/BDNF signaling and anti-neuroinflammatory effects","volume":"34","author":"Feng","year":"2019","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejphar.2026.179084_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/10408369991239213","article-title":"Cyclic nucleotide-dependent protein kinases: intracellular receptors for cAMP and cGMP action","volume":"36","author":"Francis","year":"1999","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.ejphar.2026.179084_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109927","article-title":"Intermittent treatment with apremilast, a phosphodiesterase-4 inhibitor, ameliorates Alzheimer\u2019s-like pathology and symptoms through multiple targeting actions in aged T2D rats","volume":"117","author":"Gomaa","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2026.179084_bib19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2147\/ITT.S305420","article-title":"The role of complement in synaptic pruning and neurodegeneration","volume":"10","author":"Gomez-Arboledas","year":"2021","journal-title":"ImmunoTargets Ther."},{"key":"10.1016\/j.ejphar.2026.179084_bib20","doi-asserted-by":"crossref","first-page":"pyaf028","DOI":"10.1093\/ijnp\/pyaf028","article-title":"Cognitive improvement effects of PF-04957325, a phosphodiesterase-8 inhibitor, in mouse models of Alzheimer's disease via modulating neuroinflammation","volume":"28","author":"Guo","year":"2025","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2026.179084_bib21","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.3390\/ijms22147475","article-title":"Autophagy and tau protein","volume":"22","author":"Hamano","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179084_bib22","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders","volume":"11","author":"Hardingham","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179084_bib23","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s43440-021-00264-w","article-title":"Roflumilast and tadalafil improve learning and memory deficits in intracerebroventricular A\u03b21\u201342 rat model of Alzheimer's disease through modulations of hippocampal cAMP\/cGMP\/BDNF signaling pathway","volume":"73","author":"Hasan","year":"2021","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2026.179084_bib24","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3390\/cells14120911","article-title":"Autophagy and Alzheimer's disease: mechanisms and impact beyond the brain","volume":"14","author":"Hein","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2026.179084_bib25","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/j.1476-5381.2010.01014.x","article-title":"Cilostazol prevents amyloid \u03b2 peptide25\u201035\u2010induced memory impairment and oxidative stress in mice","volume":"161","author":"Hiramatsu","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179084_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2022.148032","article-title":"Vinpocetine and coenzyme Q10 combination alleviates cognitive impairment caused by ionizing radiation by improving mitophagy","volume":"1792","author":"Hu","year":"2022","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2026.179084_bib27","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s11011-018-0256-9","article-title":"Novel action of vinpocetine in the prevention of paraquat-induced parkinsonism in mice: involvement of oxidative stress and neuroinflammation","volume":"33","author":"Ishola","year":"2018","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejphar.2026.179084_bib28","doi-asserted-by":"crossref","first-page":"9795","DOI":"10.1073\/pnas.0914414107","article-title":"Vinpocetine inhibits NF-\u03baB\u2013dependent inflammation via an IKK-Dependent but PDE-independent mechanism","volume":"107","author":"Jeon","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejphar.2026.179084_bib29","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/cbdd.14175","article-title":"Role of calcium dysregulation in Alzheimer's disease and its therapeutic implications","volume":"101","author":"Joshi","year":"2023","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejphar.2026.179084_bib30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13195-022-01034-3","article-title":"Phosphodiesterase 5 inhibitor mirodenafil ameliorates Alzheimer-like pathology and symptoms by multimodal actions","volume":"14","author":"Kang","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.ejphar.2026.179084_bib31","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/nn.2340","article-title":"Roles of stargazin and phosphorylation in the control of AMPA receptor subcellular distribution","volume":"12","author":"Kessels","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179084_bib32","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1007\/s10787-022-01010-1","article-title":"Phosphodiesterase (PDE) III inhibitor, Cilostazol, improved memory impairment in aluminum chloride-treated rats: modulation of cAMP\/CREB pathway","volume":"30","author":"Khalifa","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejphar.2026.179084_bib33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.freeradbiomed.2013.01.031","article-title":"Phosphodiesterase-5 inhibitor tadalafil attenuates oxidative stress and protects against myocardial ischemia\/reperfusion injury in type 2 diabetic mice","volume":"60","author":"Koka","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2026.179084_bib34","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.biopha.2017.01.059","article-title":"Inhibitor of Phosphodiestearse-4 improves memory deficits, oxidative stress, neuroinflammation and neuropathological alterations in mouse models of dementia of Alzheimer's type","volume":"88","author":"Kumar","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.179084_bib35","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neuroscience.2025.10.050","article-title":"Tangles and plaques: a deep dive into the pathological hallmarks of Alzheimer's disease","volume":"590","author":"Kumari","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2026.179084_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107475","article-title":"Cyclic nucleotide phosphodiesterases: new targets in the metabolic syndrome?","volume":"208","author":"Lugnier","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2026.179084_bib37","first-page":"9","article-title":"Cyclic nucleotides signaling pathways and human diseases: potential therapeutic agents in the management of such disease States","volume":"6","author":"Mbah","year":"2022","journal-title":"EC Emerg. Med. Crit. Care"},{"key":"10.1016\/j.ejphar.2026.179084_bib38","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.3390\/ijms15034671","article-title":"Tau protein modifications and interactions: their role in function and dysfunction","volume":"15","author":"Mietelska-Porowska","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179084_bib39","first-page":"1","article-title":"Cyclic adenosine monophosphate: recent and future perspectives on various diseases","volume":"12","author":"Muthal","year":"2022","journal-title":"J. Appl. Pharmaceut. Sci."},{"key":"10.1016\/j.ejphar.2026.179084_bib40","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00401-024-02799-7","article-title":"Autophagy\u2013lysosomal-associated neuronal death in neurodegenerative disease","volume":"148","author":"Nixon","year":"2024","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejphar.2026.179084_bib41","article-title":"Potent PDE4 inhibitor activates AMPK and Sirt1 to induce mitochondrial biogenesis","volume":"16","author":"Park","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.179084_bib42","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/ddr.10398","article-title":"Differential effect of the PDE5 inhibitors, sildenafil and zaprinast, in aging\u2010and lipopolysaccharide\u2010induced cognitive dysfunction in mice","volume":"63","author":"Patil","year":"2004","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejphar.2026.179084_bib43","first-page":"231","article-title":"The phosphodiesterase-4 inhibitor Ro 20-1724 reverses learning and memory impairments, and downregulation of CREB in the hippocampus and cortex induced by ketamine anesthesia in immature rats","volume":"58","author":"Peng","year":"2014","journal-title":"J. Neurosurg. Sci."},{"key":"10.1016\/j.ejphar.2026.179084_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104052","article-title":"Restoring the epigenome in Alzheimer's disease: advancing HDAC inhibitors as therapeutic agents","volume":"29","author":"Pereira","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2026.179084_bib45","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/brain\/awq342","article-title":"Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia","volume":"134","author":"Picconi","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2026.179084_bib46","doi-asserted-by":"crossref","first-page":"8075","DOI":"10.1523\/JNEUROSCI.0864-09.2009","article-title":"Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-$\u03b2$ load in an Alzheimer's disease mouse model","volume":"29","author":"Puzzo","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179084_bib47","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s11064-024-04156-2","article-title":"Phosphodiesterase 8 (PDE8): distribution and cellular expression and association with alzheimer's disease","volume":"49","author":"Qiu","year":"2024","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2026.179084_bib48","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1166\/jpsp.2017.1084","article-title":"Synergistic neuroprotective potential of combined treatment with vinpocetine and minocycline against streptozotocin and lipopolysaccharide induced memory impaired mice","volume":"3","author":"Rai","year":"2017","journal-title":"J. Pharm. Sci. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179084_bib49","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3390\/cells8050488","article-title":"Defective autophagy and mitophagy in alzheimer \u2019 s disease","volume":"8","author":"Reddy","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2026.179084_bib50","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3389\/fncel.2019.00432","article-title":"Phosphodiesterase-2 inhibitor bay 60-7550 ameliorates A\u03b2-induced cognitive and memory impairment via regulation of the HPA axis","volume":"13","author":"Ruan","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179084_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-62703-459-3_1","article-title":"NO\/cGMP: the past, the present, and the future","volume":"1020","author":"Russwurm","year":"2013","journal-title":"Guanylate Cyclase Cycl. GMP Methods Protoc."},{"key":"10.1016\/j.ejphar.2026.179084_bib52","first-page":"24","article-title":"Ameliorative effect of apremilast on scopolamine-induced alzheimer in Wistar rats","volume":"1","author":"Saifi","year":"2023","journal-title":"Int. J. Res. Pharm Allied Sci."},{"key":"10.1016\/j.ejphar.2026.179084_bib53","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3389\/fnbeh.2015.00347","article-title":"Epigenetic alterations in Alzheimer's disease","volume":"9","author":"Sanchez-Mut","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179084_bib54","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3233\/ADR-200166","article-title":"Sildenafil for the treatment of alzheimer's disease: a systematic review","volume":"4","author":"Sanders","year":"2020","journal-title":"J. Alzheimer\u2019s Dis. reports."},{"key":"10.1016\/j.ejphar.2026.179084_bib55","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3233\/ADR-200191","article-title":"Phosphodiesterase inhibitors for Alzheimer's disease: a systematic review of clinical trials and epidemiology with a mechanistic rationale","volume":"4","author":"Sanders","year":"2020","journal-title":"J. Alzheimer\u2019s Dis. Reports"},{"key":"10.1016\/j.ejphar.2026.179084_bib56","first-page":"511","article-title":"Tadalafil modulates intracerebroventricular streptozotocin-induced cognition and memory impairment in the young and middle-aged rats","volume":"27","author":"Shahidi","year":"2021","journal-title":"Pharm. Sci."},{"key":"10.1016\/j.ejphar.2026.179084_bib57","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ejphar.2013.06.038","article-title":"Phosphodiesterases: regulators of cyclic nucleotide signals and novel molecular target for movement disorders","volume":"714","author":"Sharma","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179084_bib58","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pbb.2012.01.004","article-title":"Neuroprotective effect of RO-20-1724-a phosphodiesterase4 inhibitor against intracerebroventricular streptozotocin induced cognitive deficit and oxidative stress in rats","volume":"101","author":"Sharma","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2026.179084_bib59","first-page":"1371","article-title":"Cyclic nucleotides signaling and phosphodiesterase inhibition: defying alzheimer's disease","volume":"21","author":"Sharma","year":"2020","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejphar.2026.179084_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12868-023-00790-8","article-title":"Neuroprotective effects of vinpocetine, as a phosphodiesterase 1 inhibitor, on long-term potentiation in a rat model of Alzheimer's disease","volume":"24","author":"Shekarian","year":"2023","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.ejphar.2026.179084_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70021","article-title":"Multimodal action of phosphodiesterase 5 inhibitors against neurodegenerative disorders: an update review","volume":"38","author":"Singh","year":"2024","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.ejphar.2026.179084_bib62","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.bbamcr.2018.07.018","article-title":"Calcium signaling in Alzheimer's disease & therapies","volume":"1865","author":"Tong","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.ejphar.2026.179084_bib63","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2174\/1570159X19666210826130210","article-title":"Neuroinflammatory signaling in the pathogenesis of Alzheimer's disease","volume":"20","author":"Uddin","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2026.179084_bib64","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbr.2016.01.031","article-title":"The PDE4 inhibitor roflumilast improves memory in rodents at non-emetic doses","volume":"303","author":"Vanmierlo","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2026.179084_bib65","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3109\/01677063.2011.630494","article-title":"The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 attenuates a scopolamine-induced deficit in a novel rodent attention task","volume":"25","author":"Vardigan","year":"2011","journal-title":"J. Neurogenet."},{"key":"10.1016\/j.ejphar.2026.179084_bib66","doi-asserted-by":"crossref","first-page":"63250","DOI":"10.1007\/s11356-021-15189-3","article-title":"Ameliorative role of rolipram, PDE-4 inhibitor, against sodium arsenite\u2013induced vascular dementia in rats","volume":"28","author":"Virk","year":"2021","journal-title":"Environ. Sci. Pollut. Res."},{"key":"10.1016\/j.ejphar.2026.179084_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417339","article-title":"Insights into the role of histone methylation in brain aging and potential therapeutic interventions","volume":"24","author":"Vitorakis","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179084_bib68","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1017\/S1461145711000836","article-title":"The phosphodiesterase-4 inhibitor rolipram reverses A\u03b2-induced cognitive impairment and neuroinflammatory and apoptotic responses in rats","volume":"15","author":"Wang","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2026.179084_bib69","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/ijnp\/pyaa048","article-title":"The phosphodiesterase-4 inhibitor roflumilast, a potential treatment for the comorbidity of memory loss and depression in Alzheimer's disease: a preclinical study in APP\/PS1 transgenic mice","volume":"23","author":"Wang","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2026.179084_bib70","first-page":"136","article-title":"Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease","volume":"3","author":"Wang","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ejphar.2026.179084_bib71","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1007\/s12035-018-1374-4","article-title":"PDE3 inhibitors repurposed as treatments for age-related cognitive impairment","volume":"56","author":"Yanai","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2026.179084_bib72","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.freeradbiomed.2009.02.006","article-title":"Epigenetics, oxidative stress, and Alzheimer disease","volume":"46","author":"Zawia","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2026.179084_bib73","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/978-3-319-58811-7_12","article-title":"The role of phosphodiesterase-2 in psychiatric and neurodegenerative disorders","volume":"17","author":"Zhang","year":"2017","journal-title":"Phosphodiesterases CNS Funct. Dis."},{"key":"10.1016\/j.ejphar.2026.179084_bib74","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2174\/1381612820666140826115245","article-title":"The roles of phosphodiesterase 2 in the central nervous and peripheral systems","volume":"21","author":"Zhang","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2026.179084_bib75","first-page":"30","volume":"819","author":"Zhang","year":"2018"},{"key":"10.1016\/j.ejphar.2026.179084_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2019.146344","article-title":"Inhibition of PDE5 attenuates streptozotocin-induced neuroinflammation and tau hyperphosphorylation in a streptozotocin-treated rat model","volume":"1722","author":"Zhu","year":"2019","journal-title":"Brain Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926005662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926005662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:32:54Z","timestamp":1786235574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926005662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":74,"alternative-id":["S0014299926005662"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179084","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From synapses to tangles: PDE inhibitors as therapeutic modulators in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179084"}}